Investor profile
BOLD Capital Partners
VC
See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
BOLD Capital Partners invests in people and technologies that transform the world, with a focus on exponential technologies — those whose capabilities improve not linearly but exponentially — to disrupt and democratize massive markets and address humanity's greatest challenges. Founded in 2015 by Peter Diamandis, the firm targets entrepreneurs who leverage advances at the convergence of the physical, digital, virtual, and biological worlds, with particular emphasis on longevity, patient-enabled health management, synthetic biology, advanced robotics, AI, and the opening of commercial space frontiers. The firm is especially interested in two transformative areas: health and life sciences (including longevity, synthetic biology, and data-driven medicine) and frontier technologies (including stratospheric drones, de-extinction, humanoids, and AI-enabled hardware). BOLD describes its investor relationship as a true partnership — 'a marriage, not a date or a fling' — getting 'in the bunker' with founders through thick and thin, acting as operator-investors who provide capital, strategic introductions, and hands-on support.
Notable quotes
“When we invest into a company, it's truly a marriage — not a date or a fling. We get in the bunker with you through thick and thin.”
“How do you fundamentally move the needle to make humanity better?”
“Whether it's a shoulder to cry on or a person to scream at, that's an important part of the role. We are capital allocators and investors, but in a lot of ways we're entrepreneurs ourselves. I'd view it almost as an operator-investor.”
Team
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| Insilico Medicine | Series C | $255m | 2021-06-22 |
| Colossal Biosciences | Seed | $15m | 2021-09-13 |
| AliveCor | Series F | — | — |
| Liquid AI | Seed | $38m | 2023-12 |
| Fountain Life | Series B | $18m | 2025-08 |
| Adaptive Security | Series A | $55m | 2025-12 |
| Bionaut Labs | Series A | — | — |
| Near Space Labs | Series A | — | — |
| Meru Health | Series B | — | — |
| LyGenesis | Convertible Note | $11m | — |
Frequent co-investors
| VC firm | Deals together |
|---|---|
| Warburg Pincus | 3 |
| B Capital Group | 3 |
| Qiming Venture Partners | 3 |
| Khosla Ventures | 2 |
| Horizons Ventures | 2 |
| Pavilion Capital | 2 |
Fit check
Is BOLD Capital Partners a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit